It’s Definitely a Beer Market

Sometimes a typo can hit the sweet spot, right? When I got the text that we're entering a beer market...well, let's just say that...

February Recap and More Thoughts From Last Week…

As I look out my office window here in NorCal and see the blossoms on the tree, it's tough to remember that it's still...

Thoughts From Last Week

This feels like a very strange time in the market. Usually markets overreact to news. Violent swings to extreme levels are the common occurrence...

ChromaDex Partners with Personalized Nutrition Company, Persona Nutrition, Expanding Global Partnership with Nestlé Health...

LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced the launch of its flagship cellular health supplement Tru Niagen®  (nicotinamide riboside) as...

Slogging Through Winter

I was skiing outside Seattle last weekend. Steven's Pass ski resort, to be precise. They have gotten a lot of snow up there this...

ChromaDex Achieves New Regulatory Milestones in the European Union & Australia

Tailwinds' Take: we remain believers in Tru Niagen and think it has a bright future. When we think the company is financed through to...

Visions of 2020

This last week was actually a very good week for the Tailwinds' portfolio. Despite the overall quiet of a holiday week (or maybe because...

LD Micro Recap and Other Thoughts From Last Week

LA is usually a great place to be in December, compared to the rest of the nation. With the weather being generally sunny and...

Several Thoughts On Micro-Cap Stocks I Follow

The market seems took a little hit this week, then bounced back. The net result of which was the wind coming out of the...

November Review

Was my sigh of relief audible everywhere? I've been doing this long enough to know that markets are cyclical and that the point of...

Deep Fried Turkey

Those who know me well are well aware that Wednesdays are my favorite night of the week. That's the night I go out mountain...

European Commission Votes in Favor on Nicotinamide Riboside Chloride as a Novel Food

LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today announced that European Member States have voted in favor of listing Nicotinamide...

Recapping The Recent Earnings Reports

The last couple weeks have seen a slew of earnings reports and, more importantly, investor update calls from companies in the Tailwinds Universe. Importantly...

ChromaDex Corporation Reports Third Quarter 2019 Financial Results

Third Quarter 2019 Highlights vs. Third Quarter 2018 Strong growth in net sales to $12.1 million, improved gross margin, and significantly improved marketing efficiency...

ChromaDex Statement Regarding the October 9th Order in the Central District of California Litigation

Tailwinds' Take: not a moment of shining glory for the court system. This whole case is an ongoing fiasco that is just wasting dual...

ChromaDex Announces $7 Million Private Placement of Common Stock

Tailwinds' Take: continued strategic interest in CDXC bodes well for future market acceptance of Tru Niagen. Revenues beat last Q and are in a...

Recapping The Week That Was…And Looking Towards Next

This was a very hectic week in the market, with major swings in the indexes and in our universe of smaller companies. Earnings season...

ChromaDex Corporation Reports Second Quarter 2019 Financial Results

Tailwinds' Take: great incremental growth. LOS ANGELES, Aug. 07, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) today reported second quarter 2019 financial results. “We successfully continue...

A Shallow Dive From The Deep South

In what is shaping up as a never-ending quest to provide newsletter coverage from anyplace not named "home", this week's letter comes from Raleigh,...

ChromaDex Corporation Reports First Quarter 2019 Financial Results

First Quarter 2019 Highlights vs. First Quarter 2018 Strong start to the year with $10.0 million of net sales, higher gross margins and increased marketing efficiency ...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.